Forbion invests in breakthrough biotech companies across all stages of pharmaceutical drug development, focusing on innovative therapies that improve human health. It also backs planetary‑health ventures through its BioEconomy fund, targeting sustainable solutions in food, agriculture, materials, and environmental technologies.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United Kingdom
25.6%United States of America
20.5%Netherlands
12.8%Germany
7.7%Switzerland
2.6%Other
10.4%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Stage agnostic
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Growth Opportunities III
Vintage 2024 • $1.3B
Ventures VII
Vintage 2024 • $979M